Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences.
about
Mobilization of hematopoietic progenitor cells in patients with liver cirrhosis.Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine.ABCG2: a perspective.Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma.ABC transporters, neural stem cells and neurogenesis--a different perspective.The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion.The amazing universe of hepatic microstructure.Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma.Hepatobiliary membrane transporters in primary biliary cirrhosis.ATP-binding cassette transporters in liver.Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease.The effect of hepatic progenitor cells on experimental hepatocellular carcinoma in the regenerating liver.Thymus cell antigen-1-expressing cells in the oval cell compartment.PharmGKB summary: very important pharmacogene information for ABCG2.Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity.Generation of multidrug resistant human tissues by overexpression of the ABCG2 multidrug transporter in embryonic stem cells.
P2860
Q33590816-B89FDF11-8A1A-4806-B63B-9C0C2EF6E7ECQ34293612-97BAE102-157E-41D7-A703-D9F148F5A557Q35016817-CD4AA4DC-3336-4FD9-AEAA-9FB5E3BA5EFBQ35757248-E4E4F81E-1908-44F4-B66C-D51F1194BCD6Q36646747-5F4408C1-2019-4C8A-AF8A-4D06F6B95E2EQ36803379-FB9F9B28-00FE-4C48-91E1-1DA48D78656CQ37337092-76E1D277-BAB6-4103-AE6D-6443C6E4ACE8Q37554392-5116212D-61FC-4FBB-995A-908E1945D314Q37566449-B41AA01A-E810-47D6-AF60-13C36D7D2347Q37821305-16F59D5A-1425-41C9-A4FC-BC070468D64FQ37969179-352CA8F2-1090-4D44-8D20-8C6A9F9BAFD8Q38150795-199516F1-38B7-445C-820D-C850F94A454FQ38737633-6134911A-9D26-4A6A-97F8-F9611D7CF8EBQ39067349-1C432861-2866-4AD2-9B06-06CE09F2EBC0Q45941154-F4444C72-A640-40F9-9317-D989D12AC3D2Q46018199-B64DFACE-BEAF-41ED-A41A-7FEFDB1B90CDQ46661060-CD2768C7-5FDD-4CDA-A90A-56127790445EQ52718852-1E94E81D-2DA6-4F9F-A35C-403E621A5C11Q53696076-2A26D9AF-614A-48E1-9CF4-D2A8EAB16254
P2860
Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Breast cancer resistance prote ...... sible functional consequences.
@en
type
label
Breast cancer resistance prote ...... sible functional consequences.
@en
prefLabel
Breast cancer resistance prote ...... sible functional consequences.
@en
P2093
P2860
P356
P1476
Breast cancer resistance prote ...... sible functional consequences.
@en
P2093
Aezam Katoonizadeh
Alfons Van Lommel
Bryon E Petersen
David Cassiman
Frederik Nevens
Johan Fevery
Jos van Pelt
Louis Libbrecht
Peter L Jansen
Sara Vander Borght
P2860
P304
P356
10.1369/JHC.5A6912.2006
P577
2006-05-18T00:00:00Z